A Prospective, Randomized Trial of Early Versus Late Tracheostomy in Trauma Patients With Severe Brain Injury

NCT ID: NCT00292097

Last Updated: 2008-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-28

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy of early conversion tracheostomy from endotracheal intubation (ET) to percutaneous, dilatational tracheostomy (PDT) in traumatic brain-injured patients requiring prolonged mechanical ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomized trial to evaluate the efficacy of early (less than or equal to 72 hours) versus late (10 to 14 days) conversion from endotracheal intubation to percutaneous, dilatational, translaryngeal tracheostomy for mechanical ventilation of traumatic brain injured patients.

The primary efficacy parameter will be the number of days on mechanical ventilation.

Secondary objectives include:

* Number of days in the hospital
* To assess the incidence of ventilator-acquired pneumonia in each group
* To assess the incidence of accidental extubation in each group
* To assess the incidence of death in each group

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Failure Traumatic Brain Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Respiratory failure Tracheostomy Percutaneous dilatation tracheostomy Endotracheal Conversion Traumatic brain injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Early conversion from endotracheal intubation to percutaneous tracheostomy for ventilator support of trauma patients with severe brain injury

Group Type EXPERIMENTAL

Early tracheostomy

Intervention Type PROCEDURE

early conversion - less than or equal to 72 hours

2

Conventional conversion from endotracheal intubation to percutaneous tracheostomy for ventilator support of trauma patients with severe brain injury

Group Type ACTIVE_COMPARATOR

Late tracheostomy

Intervention Type PROCEDURE

Late conversion (10-14 days)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early tracheostomy

early conversion - less than or equal to 72 hours

Intervention Type PROCEDURE

Late tracheostomy

Late conversion (10-14 days)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* TBI defined as penetrating or blunt brain injury including 1)subarachnoid hemorrhage, 2)subdural hemorrhage, 3) epidural hemorrhage, 4)brain contusion, 5)diffuse axonal injury
* mechanically ventilated by endotracheal intubation
* projected to need ventilation support for more than 14 days according to: GCS measured in field less than or equal to 8 and a GCS on day 3 which remains less than or equal to 8
* informed consent obtained from patient or legal representative

Exclusion Criteria

* less than 18 years of age
* projected to need ventilation support for less than 14 days
* anatomical deformity of the neck, including thyromegaly and cervical tumors
* previous tracheostomy
* uncontrolled coagulopathy
* existence of platelet count less than 50,000/mm2
* anti-platelet agents
* clinical evidence of ongoing infection at the proposed tracheostomy site as per physician
* mechanical ventilation with a positive end-expiratory pressure greater than 12 cm H20
* intubated more than 72 hours
* patient has undergone cricothyroidotomy
* cricoid cartilage, trachea, or sternal notch not palpable with neck in position
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Memorial Medical Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Russell D Dumire, MD

Role: PRINCIPAL_INVESTIGATOR

Memorial Medical Center

Stephen L Miller, MD

Role: PRINCIPAL_INVESTIGATOR

Memorial Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Medical Center

Johnstown, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MMC 05-27

Identifier Type: -

Identifier Source: org_study_id